Synthetic Porcine Secretin

About ChiRhoClin

Founded in 1991 by Dr. Edward D. Purich, ChiRhoClin is a specialized pharmaceutical company dedicated to orphan theranostics for gastrointestinal and pancreatic disorders. Its core achievement is the FDA approval and commercialization of ChiRhoStim® (Synthetic Human Secretin), used in diagnostic pancreatic function tests and to facilitate endoscopic retrograde cholangiopancreatography (ERCP). The company maintains a research-oriented culture, supports academic research through grant programs, and collaborates with major medical institutions on ongoing clinical studies in pancreatic cancer and pancreatitis.

Therapeutic Areas